Replies to post #16978 on NDT Pharmaceuticals Inc (NDTP)

[Ecomike]

The $NDTP chase for shares is on.

2020 article EGCG Green tea extract nano particle delivery R&D paper.

The work continues world wide on what Hovis and Michael Fountain started in 2007 and 2010 and turned into CCA, LLC in 2013 with Kubin and Dr Cohen And Mathias, et. al. at UPennMed (2013-2020) and the Univ of So Florida in 2019. This means to me we are 10 years ahead of the pack with real trials, in real people, including the Young girl with #TBI brain damage in the 2016 UPennMed Dr. Cohen paper I found earlier this year. This paper tells us the market is ready and understands the potential for $NDTP nano Particle Complex delivery technology. I have another paper I will share later calling this 164 Billion market potential this year.

https://reader.elsevier.com/reader/sd/pii/S1773224719315825?token=A45FC86010C25C275721C259A53340CC21F2B4B0827AA74F789E7B891C476EB3A197E20E3358B559D32FC4543DC92CDB

"Role of a novel (-)-epigallocatechin-3-gallate (EGCG) delivery system on the prevention against oxidative stress damagein vitroandin vivomodel of Parkinson's disease"


EGCG(Green Tea extract) in other words and Parkinsons disease

$NDTP seems to be 10+ years ahead of them.

* "Epigallocatechin-3-gallate (EGCG) is an antioxidant molecule that is studied, in this work, to evaluate its at-tenuating effect of the oxidative stress (OS) damage involved with the Parkinson disease (PD).

To optimize the EGCG antioxidant effect, an appropriate deliver system is proposed that protects its stability and bioactivity and allows having a controlled delivery at the level of concentration required for obtaining such effect."

This is one of hundreds of papers I DD'd on the story behind the curtain at $NDTP.